GPOPlus+ Announces the Launch of AntigenTests.com, a Project of HealthGPO
GPOX has launched AntigenTests.com, a project under HealthGPO, to provide competitive pricing and a reliable supply chain for FDA EUA approved Rapid Point-of-Care COVID-19 tests. This initiative aims to resolve issues of unreliable supply chains and inconsistent pricing that have plagued the market. The company highlights that the demand for COVID tests is expected to grow, particularly with new variants. Shareholders can expect potential revenue and membership growth as HealthGPO addresses these challenges effectively.
- Launch of AntigenTests.com to provide competitive pricing for COVID-19 tests.
- Addresses supply chain reliability and pricing inconsistencies.
- Expected growth in demand for COVID tests due to new variants.
- Potential for increased membership in HealthGPO.
- None.
AntigenTests.com provides HealthGPO Members and Point-of-Care (POC) providers with competitive pricing and a reliable supply chain for FDA EUA approved Rapid POC COVID-19 tests
LAS VEGAS, NV, Dec. 20, 2021 (GLOBE NEWSWIRE) -- GPO Plus, Inc. (OTCQB: GPOX), a publicly traded company of diversified industry-specific Group Purchasing Organizations or “GPOs”, today announced the official launch of AntigenTests.com, a project of HealthGPO. HealthGPO is a Group Purchasing Organization for the Healthcare industry with operations and facilities located throughout the United States.
The purpose of AntigenTests.com is to provide HealthGPO Members and Point-of-Care providers with competitive pricing and a reliable supply chain for POC COVID-19 tests.
AntigenTests.com is a project created and managed by HealthGPO. HealthGPO started distributing FDA Emergency Use Authorization (EUA) Rapid Point-of-Care (POC) COVID-19 Antigen Tests and Rapid POC COVID-19 Antibody Tests in October 2020; immediately after the initial FDA EUA’s were granted.
AntigenTests.com solves two major problems typically associated with purchasing POC COVID-19 tests:
- Unreliable supply chains with global shortages, and
- Wildly inconsistent pricing with regular price increases.
HealthGPO addresses these problems with its dedicated team of procurement professionals to ensure its Members have extremely competitive pricing and a consistent and reliable supply chain for POC COVID-19 Antigen Tests and Antibody Tests.
- HealthGPO aggregates the purchasing power of its Members to negotiate discounts with suppliers that are then shared with its Members; saving its Members money!
- HealthGPO’s procurement team works with multiple distributors and vendors to secure the most popular POC COVID-19 tests; creating reliable supply chains!
Point-of-Care providers are encouraged to visit AntigenTests.com to review our pricing and sign up as a Member of HealthGPO. Since we are not charging membership fees at this time, to become a Member all you have to do is complete a purchase.
HealthGPO Members are always incentivized to spread the word because, in the spirit of Group Purchasing, our buying power increases with each new Member. The more buying power we have the better prices we can negotiate and the more money we save our Members!
GPOX President Ron McCormick said, “Over the last year we (HealthGPO) have worked tirelessly to maintain a consistent supply of POC COVID tests while preserving the best and most competitive pricing available.” McCormick Continued, “One of the best things we’ve been able to do is to help POC facilities from getting massive fines. Due to the COVID test supply shortages, one of our main value propositions has been getting tests delivered the next day! As long as the order is paid for by 6:00 PM Eastern, we can usually get the tests delivered the next business day. Now our Members don’t have to worry about the supply chain issues.”
“Shareholders who looked closely at our filings could identify that a large portion of our revenue last year (2021) was derived from POC COVID test sales,” said GPOX CEO Brett H. Pojunis. Pojunis continued, “The importance of this project (AntigenTests.com) cannot be overstated! With the emergence of new more contagious COVID variants such as Delta and Omicron, we believe the demand for COVID tests will continue to increase greatly leading to long term growth in this sector. This creates an opportunity for us to grow HealthGPO’s Membership because we are in a position to truly help POC healthcare and medical providers who are struggling to get the tests they need.”
Rapid Point-of-Care COVID-19 Antigen Tests detect the presence or absence of SARS-CoV-2 viral protein which is the virus that causes COVID-19. Rapid Point-of-Care (POC) tests provide results within minutes (depending on the test) and are used to diagnose current or detect past SARS-CoV-2 infections in various settings, such as Physician offices, Urgent care facilities, Pharmacies, School health clinics, long term care facilities, and nursing homes, and temporary locations, such as drive-through sites managed by local organizations.
All COVID-19 tests distributed through AntigenTests.com are authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. AntigenTests.com is dedicated to Point-of-Care medical professionals.
Equity Crowdfunding Page
GPOX is raising
Sign up for your FREE account on the GPOX Investor Relations Portal:
Once you Activate your GPOX Investor Account you will have immediate access to real time information available on GPOX. Sign up for alerts (email and SMS) to be the first to know about news, SEC Filings, Investor Events, updated Investor Presentations, and more: www.GPOPlus.com/ir.
About AntigenTests.com
AntigenTests.com is a project created and managed by HealthGPO that has a dedicated team of procurement professionals to ensure our Members have a consistent supply chain for POC COVID-19 tests with competitive pricing.
Please visit: AntigenTests.com to learn more or call us at 844.998.2433.
About HealthGPO
HealthGPO is a Group Purchasing Organization or “GPO” for the Healthcare industry. HealthGPO saves its Members money by aggregating purchases, negotiating with vendors, and sharing the discounts. HealthGPO saves its Members time and alleviates headaches by streamlining orders and offering integrated solutions leading to considerable supply chain efficiencies.
For more information, please visit HealthGPO.com. To connect with a HealthGPO Team Member, email us at members@healthgpo.com, or call us at +1 (844) 998-2433.
About GPOPlus+ (GPOX)
Headquartered in Las Vegas, Nevada, GPOPlus+ (OTCQB: GPOX) is a publicly traded company of diversified industry-specific Group Purchasing Organizations or “(GPOs”. Our Purpose is to create industry specific GPOs and our Mission is to create value for our Members, partners, and suppliers while creating long term shareholder value.
Our Mantra:
We Aggregate, Negotiate + Share!
- Aggregate - We aggregate the purchasing power of our Members.
- Negotiate - We leverage buying power to negotiate discounts.
- Share - We share the discounts with our Members and save them money.
For more information, please visit www.GPOPlus.com. To activate your free GPOX Investor Account at www.GPOPlus.com/ir.
Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include statements regarding expected financial performance and growth information relating to future events.
Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond the control of the Company and its officers and managers, and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to; inability to gain or maintain licenses, reliance on unaudited statements, the Company’s need for additional funding, governmental regulation of the cannabis industry, the impact of competitive products and pricing, the demand for the Company’s products, and other risks that are detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. All statements other than statements of historical fact are statements that could be forward-looking statements. You can typically identify these forward-looking statements through use of words such as “may,” “will,” “can” “anticipate,” “assume,” “should,” “indicate,” “would,” “believe,” “contemplate,” “expect,” “seek,” “estimate,” “continue,” “plan,” “point to,” “project,” “predict,” “could,” intend,” “target,” “potential,” and other similar words and expressions of the future. The Company expresses its expectations, beliefs and projections in good faith and believes that its expectations reflected in these forward-looking statements are based on reasonable assumptions. However, there is no assurance that these expectations, beliefs and projections will prove to have been correct. Such statements reflect the current views of the Company with respect to its operations and future events, and are subject to certain risks, uncertainties and assumptions relating to its proposed operations, including the risk factors set forth herein. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, the Company’s actual results may vary significantly from those intended, anticipated, believed, estimated, expected or planned. In light of these risks, uncertainties and assumptions, any favorable forward-looking events discussed herein might not be realized and occur. The Company has no obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. For a more detailed description of the risk factors and uncertainties affecting GPO Plus, Inc. GPOX, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
GPO Plus’s Contacts:
Shareholder Success Team + Investor Inquiries:
Brett H. Pojunis, CEO Email: ir@gpoplus.com
Shareholder’s Line: 855.935.GPOX (4769)
Attachment
FAQ
What is the purpose of AntigenTests.com by GPOX?
When was AntigenTests.com launched?
How does GPOX plan to support healthcare providers?
What are the benefits for HealthGPO members after the launch of AntigenTests.com?
How is GPOX addressing the challenges in COVID-19 testing supply?
